mefloquine has been researched along with Plasmodium vivax Malaria in 75 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 22 (29.33) | 18.2507 |
2000's | 27 (36.00) | 29.6817 |
2010's | 23 (30.67) | 24.3611 |
2020's | 3 (4.00) | 2.80 |
Authors | Studies |
---|---|
Boechat, N; Campos Aguiar, AC; da Silva Araújo, M; Krettli, AU; Medeiros, JF; Penna-Coutinho, J; Pereira, DB; Rios, CT; Sá, PM | 1 |
Sibley, CH | 1 |
Banic, DM; Baptista, BO; Bianco-Junior, C; Carvalho, LJM; Cassiano, GC; Daniel-Ribeiro, CT; de Oliveira-Ferreira, J; Lima-Junior, JDC; Machado, RLD; Perce-Da-Silva, DS; Pratt-Riccio, LR; Riccio, EKP; Storti-Melo, LM; Torres, VR; Totino, PRR | 1 |
Kim, S; Lek, D; Mairet-Khedim, M; Popovici, J; Roesch, C; Witkowski, B | 1 |
Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
Alecrim, MG; Brasil, LW; Chehuan, YF; Costa, JS; Costa, MR; Lacerda, MV; Melo, GC; Monteiro, WM; Nogueira, F; Silveira, H | 1 |
Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
Dow, GS; McCarthy, WF; Reid, M; Shanks, GD; Smith, B; Tang, D | 1 |
David, K; Møller, CH | 1 |
Chotivanich, K; Chu, CS; McGready, R; Nosten, F; Tun, NW; White, NJ; Wongsaen, K | 1 |
Albrecht, L; Angerami, RN; Castiñeiras, CM; Costa, FT; Dos-Santos, JC; Garcia, MT; Lacerda, MV; Levy, CE; Lopes, SC; Moretti, ML | 1 |
Arboleda, M; Blair, S; Fernández, D; Garavito, G; Pabón, A; Segura, C | 1 |
Andrianaranjaka, V; Barnadas, C; Benedet, C; Bouchier, C; Durand, R; Khim, N; Kim, S; Legrand, E; Ménard, D; Menegon, M; Mercereau-Puijalon, O; Musset, L; Nour, BY; Popovici, J; Ratsimbasoa, A; Severini, C; Thellier, M; Tichit, M | 1 |
Changpradub, D; Mungthin, M | 1 |
Auburn, S; Handayuni, I; Marfurt, J; Noviyanti, R; Pava, Z; Poespoprodjo, JR; Price, RN; To, S; Trianty, L; Wirjanata, G | 1 |
Bannister-Tyrrell, M; Coosemans, M; d'Alessandro, U; Dierickx, S; Durnez, L; Erhart, A; Gerrets, R; Gryseels, C; Hausmann-Muela, S; Hoibak, S; Muela Ribera, J; Peeters Grietens, K; Phoeuk, P; Set, S; Sluydts, V; Suon, S; Tho, S; Trienekens, S; Uk, S | 1 |
Anstey, NM; Auburn, S; Barber, BE; Edstein, MD; Grigg, MJ; Menon, J; Price, RN; Rajahram, GS; Wilkes, CS; William, T; Yeo, TW | 1 |
Amato, R; Auburn, S; Drury, E; Handayuni, I; Kwiatkowski, DP; Miotto, O; Nosten, F; Pearson, RD; Price, RN; Russell, B; Serre, D; Sriprawat, K; Stalker, J; Suwanarusk, R; To, S | 1 |
Benchetrit, A; Couto, E; Echazarreta, S; García, J; Lloveras, S; Orduna, T; Seijo, A | 1 |
Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
Barreto Miranda, I; Löscher, T | 1 |
Chandra, A; Dutta, V; Naidu, S; Puri, P; Saha, A; Seth, AK | 1 |
Ashley, E; Aung, PP; Imwong, M; Kyaw, MK; Lee, SJ; Myint, NZ; Naing, AL; Nyo, MY; Oo, AP; Phe, O; Smithuis, F; White, NJ; Win, T | 1 |
Park, JM; Sung, YH | 1 |
Terlouw, DJ; van Eijk, AM | 1 |
Borer, A; Kafka, M; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolyakov, R | 1 |
Boulos, M; Daher, A; dos Santos, RL; Junger, W; Ladislau, JL; Leon, AP; Lucena, MB; Magalhães, I; Marchesini, PB; Ribeiro, I; Santelli, AC | 1 |
Abdur, R; Barrette, A; Bouth, DM; Duong, S; Leang, R; Menard, D; Ringwald, P | 1 |
Kain, KC; Ohrt, C; Sutamihardja, MA; Tang, D | 1 |
Wooltorton, E | 1 |
Pfeifer, C; Strauss, R | 1 |
Peters, W; Robinson, BL; Stewart, LB | 1 |
Ayomi, E; Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Elyazar, IR; Fryauff, DJ; Marwoto, H; Richie, TL | 1 |
Cetron, M; Kozarsky, P; Parise, M; Schwartz, E | 1 |
Brockman, A; Katterman, N; Kyaw, MK; Lwin, S; Smithuis, F; van der Broek, I; White, NJ | 1 |
Hayton, K; Su, XZ | 1 |
Alecrim, WD; Daniel-Ribeiro, CT; Martínez-Espinosa, FE | 1 |
Brega, S; Cheminel, V; de Monbrison, F; Gérôme, P; Peyron, F; Picot, S; Velut, G | 1 |
Acikel, CH; Dogru, T; Harlak, A; Hayat, L; Keskin, O; Kilic, S; Kocar, IH; Polat, Z; Sonmez, A; Yilmaz, MI | 1 |
Baird, JK; Fryauff, DJ; Maguire, JD; Marwoto, H; Richie, TL | 1 |
Vinetz, JM | 1 |
Ashley, EA; Brockman, A; Carrara, VI; Gilbos, V; Krudsood, S; Leemingsawat, S; Looareesuwan, S; McGready, R; Nosten, F; Proux, S; Rojanawatsirivet, C; Singhasivanon, P; Sirilak, S; Thonglairuam, J; White, N | 1 |
Ashley, EA; Barends, M; Leowattana, W; Lwin, KM; McGready, R; Nawamaneerat, W; Nosten, F; Olliaro, P; Phaiphun, L; Proux, S; Simon, WH; Singhasivanon, P; Stepniewska, K; Taylor, W; Thwai, KL; Wangseang, N; White, NJ | 1 |
Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
Congpuong, K; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Woitsch, B | 1 |
Dubberke, ER; Weil, GJ | 1 |
Basco, LK; Le Bras, J; Makler, MM; Marquet, F | 1 |
Hovette, P; Martet, G; Merouze, F; Nicolas, P; Touze, JE | 1 |
Boudreau, E; Bunnag, D; Chongsuphajaisiddhi, T; Maelankiri, L; Nopdonrattakoon, L; Nosten, F; Tangkitchot, S; ter Kuile, F; White, NJ | 1 |
Davis, DR; Hutton, DC; Rieckmann, KH; Simpson, R; Wheatley, PF; Yeo, AE | 1 |
Green, MD; Hopperus Buma, AP; Kager, PA; Kyle, DE; Lobel, HO; Ohrt, C; Tendeloo, DC; Todd, GD; van Ameijden, EJ; van Gool, T; van Thiel, PP; Veltink, RL | 1 |
Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO; White, NJ | 1 |
DeFraites, RF; Kain, KC; Magill, AJ; Smoak, BL; Wellde, BT | 1 |
Barguil, Y; Descamps, I; Genelle, B; Levenes, H; Monchy, D | 1 |
Boele van Hensbroek, M; Kager, PA; Wetsteyn, JC; Zijlmans, CW | 1 |
Schwartz, E; Sidi, Y | 1 |
Coyne, PE; Lobel, HO; Rosenthal, PJ | 1 |
Bourgeade, A; Delmont, J | 1 |
Hien, TT; Nosten, F; White, NJ | 1 |
Collins, WE; Galland, GG; Kaslow, DC; Lal, AA; Morris, CL; Saekhou, AM; Sullivan, JS; Xiao, L; Yang, C | 1 |
Botella de Maglia, J; Espacio Casanovas, A | 1 |
Dalvi, SS; Gogtay, NJ; Kshirsagar, NA; Rajgor, D; Wakde, M | 1 |
Matalon, A; Yinnon, A | 1 |
Collins, WE; Fryauff, DJ; Galland, GG; Jennings, V; Kendall, J; Morris, CL; Sullivan, JS | 1 |
Bhagwat, AN; Bhatt, R; Godse, C; Joshi, J; Vaidya, AD; Vaidya, RA | 1 |
Hassoun, PM; Kogelman, L; McGovern, B; Tanios, MA | 1 |
Croft, AM; Geary, KG | 1 |
World, MJ | 1 |
Collignon, PJ | 1 |
Amor, D; Richards, M | 1 |
Thomas, JE | 1 |
Shanks, GD; Suriyamongkol, V; Timsaad, S | 1 |
Boudreau, EF; Chaikummao, S; Pang, LW; Witayarut, C | 1 |
8 review(s) available for mefloquine and Plasmodium vivax Malaria
Article | Year |
---|---|
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Genetic and biochemical aspects of drug resistance in malaria parasites.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Resistance; Drug Resistance, Multiple; Humans; Linkage Disequilibrium; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
[The treatment of malaria].
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Pregnancy; Primaquine | 1997 |
Use of artemisinin derivatives for the control of malaria.
Topics: Antimalarials; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Prospective Studies; Refugees; Risk Factors; Seasons; Sesquiterpenes; Thailand; Treatment Outcome; Vietnam | 1998 |
The malaria threat.
Topics: Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Health Policy; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Proguanil | 2001 |
12 trial(s) available for mefloquine and Plasmodium vivax Malaria
Article | Year |
---|---|
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria, Vivax; Male; Mefloquine; Middle Aged; Plasmodium vivax; Treatment Outcome; Young Adult | 2016 |
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2010 |
Malaria in a cohort of Javanese migrants to Indonesian Papua.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Incidence; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Papua New Guinea; Parasitemia; Prevalence; Transients and Migrants | 2003 |
Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Rural Health; Sesquiterpenes | 2004 |
Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Resistance; Humans; Indonesia; Japan; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Treatment Outcome | 2006 |
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quality Control; Sesquiterpenes; Tablets; Thailand; Treatment Outcome | 2006 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study.
Topics: Adult; Anemia; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Myanmar; Outcome Assessment, Health Care; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Thailand | 1994 |
Recent military experience with malaria chemoprophylaxis.
Topics: Antimalarials; Australia; Chloroquine; Dapsone; Doxycycline; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Personnel; Primaquine; Pyrimethamine | 1993 |
Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia.
Topics: Adolescent; Adult; Animals; Antimalarials; Cambodia; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Military Personnel; Netherlands | 1996 |
Mefloquine in infants and young children.
Topics: Administration, Oral; Adult; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Prospective Studies; Random Allocation; Vomiting | 1996 |
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Antimalarials; Cambodia; Chloroquine; Confidence Intervals; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Survival Analysis; Thailand | 1991 |
55 other study(ies) available for mefloquine and Plasmodium vivax Malaria
Article | Year |
---|---|
MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax | 2021 |
A Breakthrough: Defining Plasmodium vivax Drug Resistance Genes.
Topics: Antimalarials; Drug Resistance; Drug Resistance, Multiple; Humans; Malaria, Vivax; Mefloquine; Plasmodium cynomolgi; Plasmodium vivax | 2023 |
Chloroquine and mefloquine resistance profiles are not related to the circumsporozoite protein (CSP) VK210 subtypes in field isolates of Plasmodium vivax from Manaus, Brazilian Amazon.
Topics: Antimalarials; Chloroquine; Genotype; Humans; Malaria, Vivax; Mefloquine; Parasitic Sensitivity Tests; Plasmodium vivax; Polymerase Chain Reaction; Protozoan Proteins | 2019 |
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; DNA Copy Number Variations; Drug Resistance; Humans; Malaria, Vivax; Mefloquine; Pharmaceutical Preparations; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines | 2020 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon.
Topics: Adolescent; Adult; Antimalarials; Brazil; Cell Survival; Child; Chloroquine; Female; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Malaria, Vivax; Male; Mefloquine; Middle Aged; Mutation, Missense; Parasitic Sensitivity Tests; Plasmodium vivax; Protozoan Proteins; Young Adult | 2013 |
A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
Topics: Aminoquinolines; Antimalarials; Australia; Chemoprevention; Endemic Diseases; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Retrospective Studies; Timor-Leste; Travel; Treatment Outcome; United States | 2014 |
Imported malaria is stable from Africa but declining from Asia.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult | 2014 |
Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Fatal Outcome; Female; Humans; Malaria, Vivax; Mefloquine; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Stillbirth; Thailand | 2014 |
Imported malaria in a non-endemic area: the experience of the university of Campinas hospital in the Brazilian Southeast.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Brazil; Chloroquine; Comorbidity; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Parasitemia; Primaquine; Recurrence; Retrospective Studies; Tertiary Care Centers; Thrombocytopenia; Travel; Young Adult | 2014 |
In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Colombia; Drug Resistance; Malaria, Vivax; Mefloquine; Parasitic Sensitivity Tests; Plasmodium vivax; Quinine | 2014 |
Effects of mefloquine use on Plasmodium vivax multidrug resistance.
Topics: Cambodia; Drug Resistance; French Guiana; Gene Expression Regulation; Humans; Madagascar; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Sudan | 2014 |
Severe vivax malaria: a case report and a literature review.
Topics: Antimalarials; Artemisinins; Artesunate; Asian People; Diagnosis, Differential; Drug Therapy, Combination; Humans; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Severity of Illness Index; Young Adult | 2014 |
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Plasmodium vivax; Protozoan Proteins; Quinolines; Transcription, Genetic; Tubulin | 2016 |
Characterizing Types of Human Mobility to Inform Differential and Targeted Malaria Elimination Strategies in Northeast Cambodia.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Disease Eradication; Health Surveys; Humans; Insect Vectors; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Transients and Migrants | 2015 |
Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand.
Topics: Antimalarials; DNA, Protozoan; Drug Resistance, Multiple; Gene Dosage; Genomics; Genotype; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Thailand | 2016 |
[Failure to radical cure in Plasmodium vivax malaria].
Topics: Adult; Antimalarials; Humans; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Recurrence; Treatment Failure | 2016 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
[Malaria--current diagnosis and therapy].
Topics: Antimalarials; Blood; Developing Countries; Diagnosis, Differential; Female; Humans; Malaria, Vivax; Mefloquine; Papua New Guinea; Philippines; Primaquine; Retreatment; Travel; Young Adult | 2009 |
Mixed Plasmodium falciparum and Plasmodium vivax malaria in orthotopic liver transplant recipient.
Topics: Adult; Antimalarials; Blood Transfusion; Cadaver; Female; Humans; Liver Cirrhosis; Liver Transplantation; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Tissue Donors; Treatment Outcome | 2009 |
[A case of malarial hepatitis by Plasmodium vivax].
Topics: Abdomen; Antimalarials; Erythrocytes; Fatigue; Hepatitis; Humans; Malaria, Vivax; Male; Mefloquine; Nausea; Plasmodium vivax; Primaquine; Ultrasonography; Young Adult | 2010 |
Eritrean and Sudanese migrants presenting with malaria in Israel.
Topics: Adult; Antigens, Protozoan; Antimalarials; Chloroquine; Eritrea; Female; Hospitalization; Humans; Israel; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Population Surveillance; Retrospective Studies; Sudan; Transients and Migrants; Treatment Outcome; Young Adult | 2011 |
Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; Drug Combinations; Female; Hospitalization; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines; Treatment Outcome; Young Adult | 2013 |
Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials.
Topics: Animals; Antimalarials; Diagnostic Errors; Double-Blind Method; Doxycycline; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Microscopy; Military Personnel; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Reference Standards; Sensitivity and Specificity; Treatment Outcome | 2002 |
Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders.
Topics: Animals; Antimalarials; Contraindications; Depression; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Psychoses, Substance-Induced; Seizures | 2002 |
Malaria in Austria 1990-2000.
Topics: Adolescent; Adult; Age Distribution; Animals; Austria; Chemoprevention; Child; Child, Preschool; Chloroquine; Disease Notification; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Patient Compliance; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Sex Distribution; Sulfadoxine | 2003 |
The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Mice; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Primaquine; Time Factors | 2003 |
Delayed onset of malaria--implications for chemoprophylaxis in travelers.
Topics: Antimalarials; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Israel; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Population Surveillance; Time Factors; Travel; United States | 2003 |
Malaria during pregnancy in a reference centre from the Brazilian Amazon: unexpected increase in the frequency of Plasmodium falciparum infections.
Topics: Adolescent; Adult; Antimalarials; Brazil; Child; Chloroquine; Cross-Sectional Studies; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Quinine | 2004 |
Absence of nucleotide polymorphism in a Plasmodium vivax multidrug resistance gene after failure of mefloquine prophylaxis in French Guyana.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Humans; Malaria, Vivax; Male; Mefloquine; Military Personnel; Mutation; Plasmodium vivax; Polymorphism, Single Nucleotide | 2005 |
The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan.
Topics: Adult; Afghanistan; Antimalarials; Chemoprevention; Doxycycline; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Patient Compliance; Surveys and Questionnaires; Treatment Outcome; Turkey | 2005 |
Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment.
Topics: Antimalarials; Drug Resistance; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine | 2006 |
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Therapy, Combination; Early Diagnosis; Female; Hospital Mortality; Hospitalization; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; National Health Programs; Parasitic Sensitivity Tests; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Refugees; Sesquiterpenes; Thailand; Tropical Climate | 2006 |
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.
Topics: Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lethal Dose 50; Malaria, Vivax; Mefloquine; Plasmodium vivax; Survival Rate; Thailand; Treatment Outcome | 2007 |
A woman from Honduras with a painful forearm and fever.
Topics: Adult; Animals; Antimalarials; Female; Fever; Honduras; Humans; Malaria, Vivax; Mefloquine; Pain; Plasmodium vivax; Primaquine; Radius Fractures; Texas; Treatment Outcome | 2008 |
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.
Topics: Animals; Antimalarials; Chloroquine; Colorimetry; Erythrocytes; Humans; L-Lactate Dehydrogenase; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Quinine | 1995 |
[Cytokines and malaria. A study of TNF-alpha, IL1-beta, IL6 and IL2R in 28 patients].
Topics: Adolescent; Adult; Amodiaquine; C-Reactive Protein; Chloroquine; Humans; Interleukin-1; Interleukin-6; Leukocyte Count; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Middle Aged; Neutrophils; Platelet Count; Prognosis; Receptors, Interleukin-2; Retrospective Studies; Tumor Necrosis Factor-alpha | 1994 |
Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Resistance; Humans; Malaria, Vivax; Male; Mefloquine; Military Personnel; Patient Compliance; Plasmodium vivax; Primaquine; Recurrence; Somalia; Surveys and Questionnaires; United States | 1997 |
[29 cases of malaria introduced into New Caledonia from 1992 to 1995].
Topics: Adolescent; Adult; Antimalarials; Female; France; Hospitalization; Humans; Incidence; Length of Stay; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; New Caledonia; Quinine; Retrospective Studies; Travel | 1997 |
New aspects of malaria imported from Ethiopia.
Topics: Animals; Antimalarials; Chloroquine; Culicidae; Disease Reservoirs; Drug Therapy, Combination; Ethiopia; Humans; Incidence; Insect Vectors; Israel; Malaria, Vivax; Mefloquine; Primaquine; Travel | 1998 |
Drug overdoses with antimalarial agents: prescribing and dispensing errors.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antimalarials; Drug Overdose; Female; Humans; Malaria, Vivax; Male; Medication Errors; Mefloquine; Middle Aged; Naphthalenes; Onychomycosis; Primaquine; Terbinafine | 1998 |
[The proper use of antimalarial drugs currently available].
Topics: Animals; Antimalarials; Chemoprevention; Chloroquine; Contraindications; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1998 |
Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys.
Topics: Adjuvants, Immunologic; Animals; Antimalarials; Disease Models, Animal; Female; Immunization; Malaria Vaccines; Malaria, Vivax; Male; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy; Vaccines, Synthetic | 1999 |
[Prevention of malaria].
Topics: Anti-Bacterial Agents; Antimalarials; Chloroquine; Doxycycline; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Proguanil; Risk Assessment; Risk Factors; Time Factors; Travel | 1999 |
An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; India; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
[Malaria in travelers returning to Israel from endemic areas: diagnosis of two patients in a family practice].
Topics: Adult; Animals; Antimalarials; Asia, Eastern; Family Practice; Female; Humans; Israel; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Middle Aged; Travel | 1999 |
Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.
Topics: Adaptation, Physiological; Adult; Amodiaquine; Animals; Antimalarials; Aotidae; Child; Chloroquine; Disease Models, Animal; Drug Resistance; Female; Humans; Indonesia; Malaria, Vivax; Male; Mefloquine; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy | 2000 |
Vivax malaria: also a challenge to biomedical sciences and services.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria, Vivax; Mefloquine; Plasmodium vivax; Primaquine | 1999 |
Acute respiratory distress syndrome complicating Plasmodium vivax malaria.
Topics: Antimalarials; Blood Gas Analysis; Boston; Critical Care; Female; Humans; Malaria, Vivax; Mefloquine; Middle Aged; Papua New Guinea; Positive-Pressure Respiration; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Travel | 2001 |
Malaria remains a military medical problem.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Global Health; Humans; Kenya; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Medicine; Military Personnel; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Sierra Leone; Treatment Failure; Treatment Outcome; United Kingdom | 2001 |
Chloroquine-resistant Plasmodium vivax: it may be a common problem.
Topics: Animals; Chloroquine; Drug Resistance; Female; Humans; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine | 1992 |
Mefloquine resistant P. vivax malaria in PNG.
Topics: Animals; Humans; Malaria, Vivax; Mefloquine; Papua New Guinea; Plasmodium vivax | 1992 |
Malaria prophylaxis.
Topics: Chloroquine; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Travel; Zimbabwe | 1991 |
Mefloquine chemoprophylaxis of soldiers on the Thai-Cambodian border.
Topics: Cambodia; Humans; Incidence; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Personnel; Thailand | 1991 |